(Total Views: 370)
Posted On: 06/10/2019 3:01:55 PM
Post# of 145920
That’s fair. I’m simply balancing the discussion on the timeline for approval if/when leronlimab is proven to treat TNBC. My thoughts are speculation just likes your thoughts and the thoughts of others are speculation. Like you said, a difference of 6-12 months for approval isn’t that big of a deal to a long term investor, but it is for patients. I’m interested to see how this plays out and if the FDA makes the right decision.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)